Recent Development in Peptide-Nanosystems for Combating Multidrug Resistant Cancer Cells
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-030-61021-0_7
Reference57 articles.
1. Abraham I, Sayed KE, Chen ZS, Guo H (2012) Current status on marine products with reversal effect on cancer multidrug resistance. Mar Drugs 10:2312–2321
2. Carlson DJ, Yenice KM, Orton CG (2011) Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process. Med Phys 38:6347–6350
3. Chen S, Fan JX, Qiu WX, Liu LH, Cheng H, Liu F, Yan GP, Zhang XZ (2017) Self-assembly drug delivery system based on programmable dendritic peptide applied in multidrug resistance tumor therapy. Macromol Rapid Commun 38(21):1700490
4. Claro B, Bastos M, Garcia-Fandino R (2018) Design and applications of cyclic peptides. In: Peptide applications in biomedicine, biotechnology and bioengineering. Woodhead Publishing, Cambridge, pp 87–129
5. Ding Y, Du C, Qian J, Dong CM (2019) NIR-responsive polypeptide nanocomposite generates NO gas, mild photothermia, and chemotherapy to reverse multidrug resistant cancer. Nano Lett 19:4362–4370
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3